A case of autoimmune retinopathy associated with thyroid carcinoma

Ocul Immunol Inflamm. 2010 Aug;18(4):322-3. doi: 10.3109/09273941003802379.

Abstract

Purpose: To report a case of autoimmune retinopathy (AIR) associated with a thyroid carcinoma.

Design: Case report.

Method: A 51-year-old Caucasian woman presented with a rapid decline in vision. Initial visual field and immunohistochemical testing revealed autoimmune retinopathy without an apparent underlying malignancy. Conventional local and systemic immunosuppressive therapies failed to halt the progression.

Results: Rituximab treatments were initiated and a slowing of visual loss was seen. Continued surveillance for malignancy revealed a thyroid adenoma, and later a thyroidectomy revealed a thyroid carcinoma.

Conclusions: This report highlights the unique presentation of AIR associated with a thyroid carcinoma, the need for continued surveillance for malignancy in cases of AIR, and the possible new use of rituximab for the treatment of AIR.

Publication types

  • Case Reports

MeSH terms

  • Adenoma / complications*
  • Adenoma / surgery
  • Antibodies, Monoclonal / therapeutic use
  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Agents / therapeutic use
  • Autoimmune Diseases / diagnosis
  • Autoimmune Diseases / drug therapy
  • Autoimmune Diseases / etiology*
  • Carcinoma / complications*
  • Carcinoma / surgery
  • Female
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Middle Aged
  • Retinal Diseases / diagnosis
  • Retinal Diseases / drug therapy
  • Retinal Diseases / etiology*
  • Rituximab
  • Thyroid Neoplasms / surgery*
  • Thyroidectomy
  • Visual Acuity / drug effects
  • Visual Fields / drug effects

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Agents
  • Immunosuppressive Agents
  • Rituximab